XenaCare Holdings Inc. (OTCBB:XCHO) (XCHO), owners of nationally branded OTC nutritional products, announces significant success with acceptance into the largest US retail markets including Florida, California, Texas, Arizona, Nevada and Hawaii.

This summer millions of consumers will be able to buy SunPill® and help protect their skin from the sun™s harmful effects in the form of a pill, says Frank Rizzo, XenaCare™s President. This can be the start of a revolution in the $2.2 billion domestic sun-care industry, now dominated by salves and lotions. SunPill® is not a replacement for topical sunscreens. The SunPill® is a dietary supplement that contains scientifically researched ingredients in a proprietary combination with powerful antioxidant properties that may help the body™s own natural defense when it comes to exposure to the sun.

XenaCare is a company with big ideas, said Rizzo. We expect to increase our marketing reach to include the approximate $5 billion world wide market for sun protection products. The original SunPill® was specifically reformulated to help defend the body™s skin from the negative effects of the sun.

The SunPill®, as it is simply called, was first introduced by founder Robert Bell (Banana Boat) through his Pure Laboratories LLC. On April 23, 2008 XenaCare purchased the total proprietary rights to the SunPill®, XenaCare is chaired by Dr. Alan Xenakis, MD, ScD, MPH, MS.

About XenaCare Holdings, Inc.

XenaCare Holdings Inc. is a fully reporting company whose stocks are quoted on the OTCBB under the symbol XCHO. For information contact Investor Relations 561-496-6676 or www.xenacare.com. The company has been in business since 2005 and currently markets The Body Replenishment System (BRS), SunPill® and the company is currently developing multiple unique products from a vegetarian based Omega 3 and Omega 6 fatty acids from micro algae. The Company™s objective is to provide unique, niche products to the consumer.

This Press Release contains or incorporates by reference forward-looking statements including certain information with respect to plans and strategies of XenaCare Holdings Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words believes, suggests, anticipates, plans, expects, and similar expressions are intended to identify forward-looking statements. There are a number of events or actual results of XenaCare operations that could differ materially from those indicated by such forward-looking statements.

XenaCare Holdings Inc., Boca Raton, FL
Frank Rizzo, President, 561-496-6676